Astrogen, Inc.
PrivateLast Round
Series C
Jan 31, 2024
Est. Valuation
$52.1M
Total Funding Raised
$35.36M
Company Overview
Astrogen, Inc. is a biotechnology company that develops small molecule-based therapies for neurological disorders such as Autism Spectrum Disorder (ASD).
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Astrogen, Inc. Comparables
Compare Astrogen, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Yamo Pharmaceuticals | 83% | |
| STALICLA | 81% | |
| Neurotech International Ltd | 81% |
Astrogen, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Jan 31, 2024 | ||||
| Strategic | Nov 29, 2023 | ||||
| Series B Extension | Jan 21, 2022 | ||||
| Series B | Dec 15, 2020 | ||||
| Series A | Nov 18, 2019 |
Astrogen, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Albatross Investment | Series B |
| BSK Investment | Series B |
| Wonik Investment Partners | Series B Extension |
| Daesung Private Equity | Series B |
| IBK Capital | Series B |
| ROI Investment Partners | Series B, Series A |
| KB Securities | Series B, Series B Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 15, 2026
Monthly visitors increased 47% MoM.
- Jan 31, 2024
Raised $9.4M from JCH-Kangwon National University Technology Holdings and KOREA PHARMA.
Astrogen, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Astrogen, Inc.'s valuation, stock price, and market status.
Is Astrogen, Inc. a public or private company?
Astrogen, Inc. is a private company.
What is the current stock price of Astrogen, Inc.?
Astrogen, Inc. is a private company, so its shares have no public market price. Caplight tracks Astrogen, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Astrogen, Inc. worth (valuation)?
Astrogen, Inc.'s valuation is estimated at $52.1M based on funding round data.
Can I buy Astrogen, Inc. stock?
Astrogen, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Astrogen, Inc.'s last funding round?
Astrogen, Inc.'s most recent funding round was Series C on January 31, 2024.
Who are the main investors in Astrogen, Inc.?
Key investors in Astrogen, Inc. include Partners Investment.
Will Astrogen, Inc. IPO soon?
No public IPO plans have been announced for Astrogen, Inc..
How can I track Astrogen, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Astrogen, Inc.'s shares on secondary markets.